ZINC plays an important role in wound healing (Pories et al., 1967) and may also be concerned with the body's attempt to localize malignant disease. The latter possibility is suggested by the finding of elevated zinc concentrations in the uninvolved portions of liver invaded by metastases (Olson, Heggen and Edwards, 1958; Wright and Dormandy, 1973) or in liver tissue when a neoplasm is present elsewhere (Olson et al., 1958; Wright and Dormandy, 1973) , and also by the inhibitory effect of oral zinc on the development of certain tumours in experimental animals (Poswilo and Cohen, 1971 ). High zinc levels might then be expected in the unaffected liver tissue in patients with primary hepatic cancer (PLC). Investigation of this possibility is complicated by the fact that PLC frequently develops in cirrhotic livers (Sagebiel, McFarland and Taft, 1963; Lin, 1970) , which may have subnormal zinc concentrations (Vallee et al., 1957; Butt and Higginson, 1957; Boyett and Sullivan, 1970) . A comparison was therefore made between the zinc levels in both cirrhotic and non-cirrhotic livers associated with PLC and those in non-cirrhotic livers without PLC.
MATERIALS AND METHODS
Tissue for zinc analysis was obtained at necropsy from 37 patients with PLC and 33 patients dying from a variety of noncancerous illnesses but whose livers were histologically normal. All the patients were Accepted 10 September 1973. negro males; the ages at the time of death of the subjects in the 2 groups were comparable. In the cancer cases, duplicate specimens were taken both from obviously cancerous tissue and from liver tissue (cirrhotic or non-cirrhotic) well away from the tumour. In 23 of these patients the liver was cirrhotic while in 11 the tumour arose in an otherwise normal liver. (In the remaining 3 the liver was so extensively invaded by tumour that it was not possible to obtain adequate samples of tissue free from malignancy.) The cirrhosis was of the macronodular (postnecrotic) variety in each case. Duplicate samples were taken from the normal liver of the non-cancerous patients. The specimens were wiped free of blood, weighed, placed in glass bottles and stored at 0°C until analysis.
At the time of analysis the tissue was transferred into a tall 125 ml Pyrex beaker and digested using a mixture of 5 ml nitric acid and 2 ml perchloric acid. The beaker was covered and gently heated on a hot plate in a fume cupboard until only a few drops of clear liquid remained. This was diluted with distilled water to a volume of 10 ml in a volumetric flask. Zinc assay was performed on a Techtron AA4 or AA5 atomic absorption spectrophotometer using standards of pure zinc metal dissolved in nitric acid. A reagent blank was taken through the digestion procedure, since even A.R. grade reagents contain small amounts of zinc. All glassware used was decontaminated with hot aqua regia, followed by thorough washing with distilled water.
The instrument settings were as follows: wavelength 214 nm, air pressure 15 psi, acetylene flow setting Ca 4, slit width 300 ,um, lamp current 6 mA, burner AB-41. 
RESULTS
The zinc concentration of the tissues analysed are shown in Fig. 1 
DISCUSSION
Liver zinc concentrations in patients dying from non-cancerous medical illnesses do not differ significantly from those dying from acute trauma (McBean et al., 1972). Our control group consisted of the former type of patient but with the added proviso that the liver was histologically normal, and the mean zinc concentration was similar to that reported by Koch et al. (1956) in normal livers.
Although haemosiderosis is common in South African negro males (Charlton, Bothwell and Seftel, 1973) , and iron and zinc metabolism is known to be interrelated (Davies, 1972) , the presence of excess tissue iron does not appear to affect hepatic zinc levels significantly (Butt and Higginson, 1957) . A wide variation in the zinc concentration of apparently normal livers has also been a feature of previous studies (Koch et al., 1956; Olson et al., 1958) .
The relationship, if any, between zinc and malignant disease is uncertain. On the one hand, excessive intake of zinc has been incriminated in the aetiology of various forms of cancer, e.g. stomach cancer in England (Stocks and Davies, 1964) and Japan (Hirayama, 1962) , and oesophageal cancer in Africa (McGlashan, 1967) , and Chahovitch (1955) has shown that injection of zinc sulphate increases experimental tumour growth. In addition, dietary zinc deficiency inhibits the growth of experimental carcinosarcomata (De Wys et al., 1970) . On the other hand, the development of other tumours in experimental animals is inhibited by oral zinc (Poswilo and Cohen, 1971) . The high zinc content in the unaffected portions of liver containing metastatic deposits and in liver tissue when a neoplasm is present elsewhere (Olson et al., 1968; Wright and Dormandy, 1973) suggests that zinc may play a role in the tissue reaction to malignant disease. This function would be expected to apply equally to tissues other than the liver, and to the growth and spread of the primary lesion as well as metastases. Our finding of normal zinc levels in non-cirrhotic liver tissue in patients with PLC therefore argues against this hypothesis, at least in as far as the South African negro is concerned.
Subnormal hepatic zinc levels occur in alcoholic cirrhosis (Vallee et al., 1957; Boyett and Sullivan, 1970) and also in South African negroes with cirrhosis (Butt and Higginson, 1957) . The latter observation was confirmed in the present study, in which the cirrhosis was of the macronodular (postnecrotic) variety. The statement by Addink and Frank (1959) that high serum zinc levels occur in association with tumours arising in tissues rich in zinc, such as the liver, would therefore not apply to PLC when cirrhosis is present. PLC is commonly associated with cirrhosis, the figure ranging from 16 to 80% in different parts of the world (MacDonald, 1957; Sagebiel, McFarland and Taft, 1963; Ying et al., 1963; Lin, 1970) . Between 50 and 100% of these tumours in the indigenous people of southern Africa occur in cirrhotic livers (Berman, 1951; Becker and Chatgidakis, 1961; Geddes and Falkson, 1970) , and in this series the figure was 66%. However, in the absence of cirrhosis the hepatic zinc concentration did not differ from that of the " control " livers, and elevated serum levels might therefore occur in these patients. The tumour itself is probably not the source of the serum zinc as the levels are low. Similar values have been reported in hepatic metastases (Olson et al., 1958) which are not associated with raised serum levels (Vikbladh, 1951; Wolff, 1956; Davies, Musa and Dormandy, 1968) .
